Key takeaways
- Fasting insulin is not a standard test used to diagnose prediabetes or type 2 diabetes.
- Laboratory methods and research cut-offs vary, so a universal optimal number is misleading.
- Ask what clinical decision a test would change before ordering it.
A fasting insulin result can answer a specialist question, but it is not a routine diagnostic test for prediabetes or type 2 diabetes. Adding it to every check-up can produce uncertainty without improving the next decision.
Insulin helps move glucose out of the bloodstream. When tissues respond less effectively, the pancreas may release more insulin to compensate. That makes measuring insulin sound like an obvious way to identify the problem early. The difficulty lies in turning the number into an agreed diagnosis or treatment plan.
A biological idea is not a standardised test
The NIDDK explains that clinicians usually diagnose prediabetes using glucose-based tests or HbA1c. Direct tests of insulin resistance are mainly used in research. A fasting insulin value also depends on the assay and clinical circumstances. An internet cut-off cannot establish a diagnosis by itself.
HOMA-IR combines fasting insulin with fasting glucose in a calculation. Giving the result a formula does not remove the limitations of the inputs. Population-specific research thresholds should not be presented as a universal boundary between healthy and unhealthy people.
PCOS illustrates why this distinction matters
Insulin resistance is important in PCOS. Yet the 2023 international PCOS guideline says routinely available insulin assays have limited clinical relevance and are not recommended for routine care. It favours an oral glucose tolerance test for assessing glycaemic status in PCOS when appropriate.
That can feel counterintuitive: if insulin is part of the condition, why not measure it? Because the best test is the one that usefully guides care. A mechanism can matter without its easiest laboratory measurement being the most useful clinical tool.
Ask the question before ordering the panel
If a test is suggested, ask what your clinician is trying to find out, how the result would be interpreted and what would change at a high or low value. There may be a good individual reason. The point is to make that reason explicit rather than treating a larger panel as automatically more thorough.
Discuss family history, gestational diabetes, medications and earlier glucose results. Symptoms such as fatigue or sleepiness alone cannot diagnose insulin resistance and deserve consideration on their own terms.
Choose a meaningful follow-up
Keep the focus on the care plan: the appropriate test, the next review and the habits or medicines being assessed. Repeating an uncertain measurement more often does not make it more informative. A clear question gives the next result somewhere useful to go.
Sources and further reading
This article provides education. A qualified clinician can interpret your results and advise on diagnosis or treatment. Read our editorial approach.
Make this useful for your own routine
Explore our insulin resistance guide and the questions to discuss with your care team.
Read the insulin resistance guide